Hearing loss in unilateral and bilateral enlarged vestibular aqueduct syndrome.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 22 08 2018
revised: 14 12 2018
accepted: 16 12 2018
pubmed: 12 1 2019
medline: 16 3 2019
entrez: 12 1 2019
Statut: ppublish

Résumé

To investigate any meaningful differences in hearing between patients with unilateral and bilateral enlarged vestibular aqueduct (EVA). EVA is a common radiological finding in children presenting with hearing loss. We hope to provide insight into the pathogenesis of EVA and provide further guidelines for unilateral EVA management. We hypothesized that hearing loss in unilateral EVA would be similar to that seen in bilateral EVA. A longitudinal retrospective study design was used. Three measures of hearing, pure tone average (PTA) word recognition score (WRS) and speech awareness threshold (SAT) and radiologic morphologies were tested for difference across unilateral versus bilateral ear EVA status. Linear mixed effects models were used to identify differences while accounting for time and multiple measurements per ear. Using Cincinnati criteria, 89 ears fit inclusion criteria, 75 of which were from patients with bilateral EVA compared to 14 ears from patients with unilateral EVA. No significant differences across bilateral status were observed in audiological measurements. Models showed that speech recognition threshold (SRT) (p = 0.925), word recognition score (WRS)(p = 0.521) and pure tone average (PTA) of air and bone conduction from 250 to 4000 Hz (p = 0.281-0.933) were not statistically different with respect to bilateral status. Wilcoxon rank-sum tests showed no statistical difference in vestibular aqueduct width or operculum size (VA)(p = 0.234, p = 0.623). Each year after the first audiogram was associated with significantly greater SRT (p = 0.003) decreased WRS (0.014) and increased PTA (0.003.). Greater midpoint width was associated with significantly lower SRT (p = 0.004) WRS (<0.001) and PTA (<0.001.) CONCLUSION: Our results indicate no statistically significant difference in hearing ability with respect to bilateral EVA status, suggesting that unilateral EVA patients require close follow-up. Our results also demonstrate the progressive nature of EVA and a relationship between VA midpoint width and hearing loss severity.

Identifiants

pubmed: 30634102
pii: S0165-5876(18)30634-7
doi: 10.1016/j.ijporl.2018.12.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-151

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Hunter D Archibald (HD)

Department of Otolaryngology, University Hospitals, Rainbow Babies and Children's Hospital and Case Western Reserve University, and Case Western Reserve University School of Medicine, USA.

Mustafa Ascha (M)

Department of Otolaryngology, University Hospitals, Rainbow Babies and Children's Hospital and Case Western Reserve University, and Case Western Reserve University School of Medicine, USA.

Amit Gupta (A)

Department of Otolaryngology, University Hospitals, Rainbow Babies and Children's Hospital and Case Western Reserve University, and Case Western Reserve University School of Medicine, USA.

Cliff Megerian (C)

Department of Otolaryngology, University Hospitals, Rainbow Babies and Children's Hospital and Case Western Reserve University, and Case Western Reserve University School of Medicine, USA.

Todd Otteson (T)

Department of Otolaryngology, University Hospitals, Rainbow Babies and Children's Hospital and Case Western Reserve University, and Case Western Reserve University School of Medicine, USA. Electronic address: todd.otteson@uhhospitals.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH